These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7757108)

  • 21. Anti-beta(2)-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein I to phospholipids.
    Izumi T; Pound ML; Su Z; Iverson GM; Ortel TL
    Thromb Haemost; 2002 Oct; 88(4):620-6. PubMed ID: 12362233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Investigation of binding capacity of beta 2-glycoprotein I with anti-beta 2-glycoprotein I antibodies in lymphocytes undergoing apoptosis].
    Kitakawa H
    Hokkaido Igaku Zasshi; 2000 Jan; 75(1):35-44. PubMed ID: 10736759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
    Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
    Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding.
    Matsuura E; Igarashi M; Igarashi Y; Nagae H; Ichikawa K; Yasuda T; Koike T
    Int Immunol; 1991 Dec; 3(12):1217-21. PubMed ID: 1777418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boar acrosin. Association of an endogenous membrane proteinase with phospholipid membranes.
    Straus JW; Parrish RF; Polakoski KL
    J Biol Chem; 1981 Jun; 256(11):5662-8. PubMed ID: 7016857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lupus anticoagulant activity is frequently dependent on the presence of beta 2-glycoprotein I.
    Oosting JD; Derksen RH; Entjes HT; Bouma BN; de Groot PG
    Thromb Haemost; 1992 May; 67(5):499-502. PubMed ID: 1519207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antiphospholipid/cofactor syndromes. II. A variant in patients with systemic lupus erythematosus with antibodies to beta 2-glycoprotein I but no antibodies detectable in standard antiphospholipid assays.
    Alarcon-Segovia D; Mestanza M; Cabiedes J; Cabral AR
    J Rheumatol; 1997 Aug; 24(8):1545-51. PubMed ID: 9263149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles.
    Chonn A; Semple SC; Cullis PR
    J Biol Chem; 1995 Oct; 270(43):25845-9. PubMed ID: 7592769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y
    Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome.
    Schwarzenbacher R; Zeth K; Diederichs K; Gries A; Kostner GM; Laggner P; Prassl R
    EMBO J; 1999 Nov; 18(22):6228-39. PubMed ID: 10562535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of beta2-glycoprotein 1 with phosphatidylserine-containing membranes: ligand-dependent conformational alterations initiate bivalent binding.
    Hamdan R; Maiti SN; Schroit AJ
    Biochemistry; 2007 Sep; 46(37):10612-20. PubMed ID: 17715943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-beta 2-glycoprotein I antibody: specificity and clinical significance.
    Koike T; Matsuura E
    Lupus; 1996 Oct; 5(5):378-80. PubMed ID: 8902764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II.
    Ma K; Simantov R; Zhang JC; Silverstein R; Hajjar KA; McCrae KR
    J Biol Chem; 2000 May; 275(20):15541-8. PubMed ID: 10809787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfatides: targets for anti-phospholipid antibodies.
    Merten M; Motamedy S; Ramamurthy S; Arnett FC; Thiagarajan P
    Circulation; 2003 Oct; 108(17):2082-7. PubMed ID: 14530197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipid-bound beta 2-glycoprotein I induces the production of anti-phospholipid antibodies.
    Subang R; Levine JS; Janoff AS; Davidson SM; Taraschi TF; Koike T; Minchey SR; Whiteside M; Tannenbaum M; Rauch J
    J Autoimmun; 2000 Aug; 15(1):21-32. PubMed ID: 10936025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flexible loop of beta 2-glycoprotein I domain V specifically interacts with hydrophobic ligands.
    Hong DP; Hagihara Y; Kato H; Goto Y
    Biochemistry; 2001 Jul; 40(27):8092-100. PubMed ID: 11434778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
    Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
    Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
    Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.